TXNIP and cancer: Furthermore, the negative regulation of glucose transporters by 1,25(OH)2D3, as shown in the case of GLUT1 in cancer cells [17,29], may reduce glucose uptake and intracellular levels of glycolytic intermediates capable of inducing TXNIP expression.